Search Results
Department of Medicine III, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse, Dresden, Germany
Department of Experimental Diabetology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
German Center for Diabetes Research (DZD), München-Neuherberg, Germany
Search for other papers by Nicole Bechmann in
Google Scholar
PubMed
Institute of Physiology, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse, Dresden, Germany
Search for other papers by Mats Leif Moskopp in
Google Scholar
PubMed
Search for other papers by Martin Ullrich in
Google Scholar
PubMed
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain
Search for other papers by Bruna Calsina in
Google Scholar
PubMed
Search for other papers by Pål William Wallace in
Google Scholar
PubMed
Search for other papers by Susan Richter in
Google Scholar
PubMed
Search for other papers by Markus Friedemann in
Google Scholar
PubMed
Search for other papers by Katharina Langton in
Google Scholar
PubMed
Search for other papers by Stephanie M J Fliedner in
Google Scholar
PubMed
Search for other papers by Henri J L M Timmers in
Google Scholar
PubMed
Search for other papers by Svenja Nölting in
Google Scholar
PubMed
Department of Endocrinology, Diabetology and Clinical Nutrition, UniviersitätsSpital Zürich, Zurich, Switzerland
Search for other papers by Felix Beuschlein in
Google Scholar
PubMed
Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Search for other papers by Aleksander Prejbisz in
Google Scholar
PubMed
Search for other papers by Karel Pacak in
Google Scholar
PubMed
Search for other papers by Hans K Ghayee in
Google Scholar
PubMed
Search for other papers by Stefan R Bornstein in
Google Scholar
PubMed
Search for other papers by Peter Dieterich in
Google Scholar
PubMed
Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Mommsenstrasse, Dresden, Germany
Search for other papers by Jens Pietzsch in
Google Scholar
PubMed
Search for other papers by Ben Wielockx in
Google Scholar
PubMed
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
German Consortium for Translational Cancer Research (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany
Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany
Department of Neuropathology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany
Search for other papers by Nan Qin in
Google Scholar
PubMed
Department of Medicine III, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse, Dresden, Germany
Search for other papers by Graeme Eisenhofer in
Google Scholar
PubMed
subunits ( SDHx ), prolyl hydroxylase domain ( PHD ), fumarate hydratase ( FH ), malate dehydrogenase 2 ( MDH2 ), mitochondrial 2-oxoglutarate/malate carrier ( SLC25A11 ), isocitrate dehydrogenases ( IDH1 / IDH2 / IDH3B ), glutamic-oxaloacetic transaminase
Search for other papers by Pamela Brock in
Google Scholar
PubMed
Search for other papers by Jennifer L Geurts in
Google Scholar
PubMed
Search for other papers by Paulien Van Galen in
Google Scholar
PubMed
Search for other papers by Erica Blouch in
Google Scholar
PubMed
Search for other papers by James Welch in
Google Scholar
PubMed
Search for other papers by Amy Kunz in
Google Scholar
PubMed
Search for other papers by Lauren Desrosiers in
Google Scholar
PubMed
Search for other papers by Jennifer Gauerke in
Google Scholar
PubMed
Search for other papers by Samuel Hyde in
Google Scholar
PubMed
evaluate the clinical validity of gene-disease relationships, for which an evidence-based framework has been published and a hereditary cancer working group convened that has already curated many HEN genes, including the SDHx genes, MAX , TMEM127 , CDC
Search for other papers by Rodrigo A Toledo in
Google Scholar
PubMed
Search for other papers by Roxanne Hatakana in
Google Scholar
PubMed
Search for other papers by Delmar M Lourenço Jr in
Google Scholar
PubMed
Search for other papers by Susan C Lindsey in
Google Scholar
PubMed
Search for other papers by Cleber P Camacho in
Google Scholar
PubMed
Search for other papers by Marcio Almeida in
Google Scholar
PubMed
Search for other papers by José V Lima Jr in
Google Scholar
PubMed
Search for other papers by Tomoko Sekiya in
Google Scholar
PubMed
Search for other papers by Elena Garralda in
Google Scholar
PubMed
Search for other papers by Michel S Naslavsky in
Google Scholar
PubMed
Search for other papers by Guilherme L Yamamoto in
Google Scholar
PubMed
Search for other papers by Monize Lazar in
Google Scholar
PubMed
Search for other papers by Osorio Meirelles in
Google Scholar
PubMed
Search for other papers by Tiago J P Sobreira in
Google Scholar
PubMed
Search for other papers by Maria Lucia Lebrao in
Google Scholar
PubMed
Search for other papers by Yeda A O Duarte in
Google Scholar
PubMed
Search for other papers by John Blangero in
Google Scholar
PubMed
Search for other papers by Mayana Zatz in
Google Scholar
PubMed
Search for other papers by Janete M Cerutti in
Google Scholar
PubMed
Search for other papers by Rui M B Maciel in
Google Scholar
PubMed
Endocrine Genetics Unit (Laboratório de Investigação Médica/LIM-25) of Hospital das Clínicas, Nursing School, School of Public Health, Human Genome Research Center, Division of Genetics, Division of Endocrinology, Brazilian National Laboratory of Biosciences, Centro Integral Oncológico Clara Campal, Department of Genetics, Endocrinology Division, Laboratory of Epidemiology and Population Sciences, University of São Paulo School of Medicine, São Paulo, São Paulo 05403-010, Brazil
Search for other papers by Sergio P A Toledo in
Google Scholar
PubMed
. Phaeochromocytoma patients initially reported to be RET Y791F-only carriers can harbour variants of other genes, e.g. VHL or SDHx , that are most probably the cause of the disease. Lesson from finding 4: Established clinical predictors and algorithms should be
Search for other papers by Erwan Thouënnon in
Google Scholar
PubMed
Search for other papers by Alice Pierre in
Google Scholar
PubMed
Search for other papers by Yannick Tanguy in
Google Scholar
PubMed
Search for other papers by Johann Guillemot in
Google Scholar
PubMed
Search for other papers by Destiny-Love Manecka in
Google Scholar
PubMed
Search for other papers by Marlène Guérin in
Google Scholar
PubMed
Search for other papers by L'houcine Ouafik in
Google Scholar
PubMed
Search for other papers by Mihaela Muresan in
Google Scholar
PubMed
Search for other papers by Marc Klein in
Google Scholar
PubMed
Search for other papers by Jérôme Bertherat in
Google Scholar
PubMed
Search for other papers by Hervé Lefebvre in
Google Scholar
PubMed
Search for other papers by Pierre-François Plouin in
Google Scholar
PubMed
Search for other papers by Laurent Yon in
Google Scholar
PubMed
Search for other papers by Youssef Anouar in
Google Scholar
PubMed
Endocrinology and Metabolism 92 4865 – 4872 . Timmers H Gimenez-Roqueplo AP Mannelli M Pacak K 2009 Clinical aspects of SDHx-related pheochromocytoma and paraganglioma . Endocrine-Related Cancer 16 391 – 400 . Turquier V Yon L Grumolato
Search for other papers by Giulia Vocino Trucco in
Google Scholar
PubMed
Search for other papers by Marco Volante in
Google Scholar
PubMed
immunohistochemistry may be used also as a complement to genetic testing. For example, in paragangliomas, loss of SDHB expression serves as a surrogate biomarker for SDHx alterations (such as germline mutations in SDHA , SDHB , SDHC , SDHD , and SDHAF2
Search for other papers by Fredrika Svahn in
Google Scholar
PubMed
Search for other papers by Karolina Solhusløkk Höse in
Google Scholar
PubMed
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Adam Stenman in
Google Scholar
PubMed
Department of Breast Surgery, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China
Search for other papers by Yaxuan Liu in
Google Scholar
PubMed
Search for other papers by Jan Calissendorff in
Google Scholar
PubMed
Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Emma Tham in
Google Scholar
PubMed
Search for other papers by Ákos Végvári in
Google Scholar
PubMed
Search for other papers by Roman A Zubarev in
Google Scholar
PubMed
Department of Medicine Huddinge, Karolinska Institutet, Huddinge, Sweden
Search for other papers by Na Wang in
Google Scholar
PubMed
Search for other papers by Reju Korah in
Google Scholar
PubMed
Carling Adrenal Center, Tampa, Florida, USA
Search for other papers by Tobias Carling in
Google Scholar
PubMed
Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Jan Zedenius in
Google Scholar
PubMed
Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Robert Bränström in
Google Scholar
PubMed
Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital Stockholm, Sweden
Search for other papers by C Christofer Juhlin in
Google Scholar
PubMed
Search for other papers by Catharina Larsson in
Google Scholar
PubMed
status and/or mRNA expression profile, tumors were assigned as cluster 1 ( SDHx , VHL , EPAS1, and EGLN1 ) or cluster 2 ( RET , NF1 , TMEM127 , MAX , and HRAS ). Fresh frozen tumor tissue samples were collected from the local Biobank for all 97
Search for other papers by Anna Angelousi in
Google Scholar
PubMed
Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
Search for other papers by Georgios Zografos in
Google Scholar
PubMed
Search for other papers by Svenja Nölting in
Google Scholar
PubMed
Division of Translational and Experimental Medicine, University of Warwick Medical School, Clinical Sciences Research Laboratories, Coventry, UK
Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Oxford, UK
Search for other papers by Gregory Kaltsas in
Google Scholar
PubMed
Search for other papers by Ashley Grossman in
Google Scholar
PubMed
studies have identified two main activated molecular pathways leading to the development of these tumours: the hypoxic (cluster-1 genes), mainly involving the succinate dehydrogenase ( SDHx ) and the Von Hippel-Lindau ( VHL ) genes, and the mTOR (cluster-2
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
Search for other papers by Samantha Peiling Yang in
Google Scholar
PubMed
Oncology Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore
Search for other papers by Joanne Ngeow in
Google Scholar
PubMed
Eng C 2012 Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53 . Human Molecular Genetics 21 300 – 310 . ( doi:10.1093/hmg/ddr459 ) Orloff MS He
Search for other papers by Jan P Dumanski in
Google Scholar
PubMed
Search for other papers by Chiara Rasi in
Google Scholar
PubMed
Search for other papers by Peyman Björklund in
Google Scholar
PubMed
Search for other papers by Hanna Davies in
Google Scholar
PubMed
Search for other papers by Abir S Ali in
Google Scholar
PubMed
Search for other papers by Malin Grönberg in
Google Scholar
PubMed
Search for other papers by Staffan Welin in
Google Scholar
PubMed
Department of Clinical Science, University of Bergen, Bergen, Norway
Search for other papers by Halfdan Sorbye in
Google Scholar
PubMed
Search for other papers by Henning Grønbæk in
Google Scholar
PubMed
Search for other papers by Janet L Cunningham in
Google Scholar
PubMed
Search for other papers by Lars A Forsberg in
Google Scholar
PubMed
Search for other papers by Lars Lind in
Google Scholar
PubMed
Search for other papers by Erik Ingelsson in
Google Scholar
PubMed
Search for other papers by Peter Stålberg in
Google Scholar
PubMed
Search for other papers by Per Hellman in
Google Scholar
PubMed
Search for other papers by Eva Tiensuu Janson in
Google Scholar
PubMed
are not enriched in frequency among all SI-NET patients, when compared to the control population. Furthermore, mutations in the SDHx genes have previously been implicated in cancer, and particularly, in forms related to SI-NETs, such as
Search for other papers by Camilo Jimenez in
Google Scholar
PubMed
Search for other papers by Sasan Fazeli in
Google Scholar
PubMed
Department of Endocrinology, Hospital Universitario San Vicente Fundacion, Medellin, Colombia
Search for other papers by Alejandro Román-Gonzalez in
Google Scholar
PubMed
mTORC1 complex is significantly overactivated in SDHX-mutated paragangliomas . Neuroendocrinology 105 384 – 393 . ( https://doi.org/10.1159/000455864 ) Parikh PP Rubio GA Farra JC Lew JI 2017 Nationwide review of hormonally active